Product Information
ACETAMINOPHEN ER 650 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0631 per EA under NDC 68001049500. Its NADAC has been published 261 times since Oct 6, 2021.
FDA first approved this application on Nov 9, 2016.
Strength
650 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001049500
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
Generic (ANDA)
FDA Application
ANDA207229FDA Approved
11/9/2016
On Market Since
4/30/2021
Price Statistics
The NADAC for ACETAMINOPHEN ER 650 MG TABLET has been published 261 times since Oct 6, 2021, and over the history we have for it it has declined 10.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0631 per EA |
|---|---|
| All-time high | $0.0759 (Mar 15, 2023) |
| All-time low | $0.0610 (May 22, 2024) |
| 52-week high | $0.0686 |
| 52-week low | $0.0629 |
| Median price | $0.0680 |
| Average price | $0.0677 |
| Largest weekly change | +16.2% (Feb 22, 2023) |
| Weeks tracked | 261 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN ER 650 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN ER 650 MG TABLET, manufactured by BluePoint Laboratories, is $0.0631 per EA (NDC 68001049500), effective Sep 30, 2026.
How has the price of ACETAMINOPHEN ER 650 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN ER 650 MG TABLET has declined 10.3%. It has been tracked across 261 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN ER 650 MG TABLET?
Since Oct 6, 2021, the NADAC for ACETAMINOPHEN ER 650 MG TABLET has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.0759 (Mar 15, 2023), with a median of $0.0680 per EA.
Are there cheaper alternatives to ACETAMINOPHEN ER 650 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ARTHRITIS PAIN ER 650 MG, is $0.0599 per EA — about 5% below ACETAMINOPHEN ER 650 MG TABLET.
Who manufactures ACETAMINOPHEN ER 650 MG TABLET?
ACETAMINOPHEN ER 650 MG TABLET (NDC 68001049500) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.